Table 2.

Reasons for referral to Phase I trials? (single choice).

(1) No other options available	31%
(2) Benefit development of new agents	25%
(3) Possibility of clinical benefit for patient	20%
(4) Patients' or families' request	10%
(5) Possibility psychological benefit for patient	8%
(6) Know about a specific ongoing trial	3%
(7) Rather than having end stage disease discussion	3%